If your software touches records from a substance use disorder treatment program, HIPAA is not the only rule that applies. A separate federal regulation, 42 CFR Part 2, has governed those records since the 1970s, and a 2024 final rule rewrote large parts of it to align more closely with HIPAA. The general compliance deadline was February 16, 2026, which means most regulated programs and the software vendors who serve them should already have updated systems in place. This article explains what Part 2 actually requires, what changed, and what it means for teams building or buying behavioral health software.
This is a technical and compliance overview for software and product teams, not legal advice. Part 2 compliance depends on how a specific program is structured, its consent forms, its business associate and qualified service organization agreements, and its clinical workflows. Confirm specifics with qualified legal counsel before relying on any system design decision described here.
What 42 CFR Part 2 Actually Protects
42 CFR Part 2 restricts the use and disclosure of records created by federally assisted programs that provide substance use disorder diagnosis, treatment, or referral. "Federally assisted" is broad: it covers programs that receive federal funding directly, are licensed or certified by a federal agency, or are run by an entity that accepts Medicare or Medicaid. In practice, this reaches far beyond dedicated addiction treatment centers and includes behavioral health units inside general hospitals, telehealth platforms offering SUD counseling, employee assistance programs, and primary care practices that identify themselves publicly as providing substance use treatment.
The rule exists because disclosure risk discourages people from seeking treatment. A record showing someone is in SUD treatment can affect employment, custody disputes, immigration status, and criminal proceedings, so Part 2 has historically been stricter than HIPAA about who can see that information and under what conditions.
How Part 2 Differs From HIPAA
HIPAA allows covered entities to use and disclose protected health information for treatment, payment, and health care operations without separate patient authorization for each use. Before the 2024 update, Part 2 required patient consent for nearly every disclosure, including routine ones between a patient's own treatment team, and once Part 2 data was disclosed to a non-Part 2 entity, strict redisclosure limits still travelled with it.
That stricter standard created real friction for integrated care. A primary care provider coordinating with a patient's SUD counselor, or a health plan processing a claim that touched Part 2 data, often could not rely on the same consent logic that governed the rest of a patient's record. Software built around a single HIPAA-style consent model would quietly violate Part 2 if it touched SUD records.
What the 2024 Final Rule Changed
The Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration and the Office for Civil Rights, published a final rule in the Federal Register on February 16, 2024, implementing changes required by Section 3221 of the CARES Act. The final rule text and the current version of 42 CFR Part 2 are both worth reading directly rather than relying only on summaries, since the specific wording of consent and redisclosure language matters for compliance.
The main changes that affect software design:
- Single consent for TPO. A patient can now sign one consent covering all future uses and disclosures of Part 2 records for treatment, payment, and health care operations, rather than a new consent for every recipient. The consent still has to identify the patient, describe the information and purpose, and include an expiration date or event, among other required elements under 42 CFR 2.31.
- A redisclosure notice instead of mandatory segregation. When Part 2 data is disclosed to a HIPAA covered entity or business associate for treatment, payment, or operations, the consent must state that the record may be redisclosed under HIPAA's rules, except for use in civil, criminal, administrative, or legislative proceedings against the patient. This replaces the older expectation that systems physically wall off Part 2 data from the rest of the record.
- Business associates folded into Qualified Service Organizations. The rule expands the definition of Qualified Service Organization to include HIPAA business associates, which brings vendors handling Part 2 data (cloud hosts, billing processors, analytics tools) into a more consistent contracting framework.
- HIPAA enforcement applies to Part 2 violations. The Office for Civil Rights now enforces Part 2 using HIPAA's civil and criminal penalty structure, instead of Part 2's older, narrower enforcement mechanism.
- Notices of Privacy Practices must be updated. HIPAA covered entities that receive or maintain Part 2 records had to update their Notices of Privacy Practices to reflect the new redisclosure and complaint rights by the compliance date.
One change that is explicitly deferred: a new Part 2 accounting-of-disclosures right exists on paper, but it will not take effect until HHS finalizes a related update to the HIPAA accounting-of-disclosures standard. Software teams do not need to build that reporting capability yet, though it is worth tracking.
The February 2026 Compliance Deadline: Where Things Stand
The rule took effect April 16, 2024, with a general compliance date of February 16, 2026, giving programs and vendors about two years to update consent forms, policies, contracts, and systems. That date has now passed. If you are building or maintaining software that touches Part 2 data and it still assumes the pre-2024 consent model, treat that as a gap to close, not a future project. If you are evaluating a vendor or an EHR module that handles behavioral health data, ask directly how their consent and redisclosure logic reflects the current rule, not the pre-2026 one.
What This Means for Software Architecture
The compliance changes translate into specific, buildable requirements rather than abstract legal language.
Consent as structured data, not a signed PDF
A single TPO consent only works operationally if the system can track what it actually authorizes: which purposes, which recipient categories, and when it expires or is revoked. Treating consent as a scanned document attached to a chart makes it nearly impossible to answer "can we disclose this record to this recipient for this purpose right now" at the moment a request comes in. That logic needs to live in structured fields the application can query, not just in a document repository.
Redisclosure notices need to travel with the data
Whenever Part 2 data is sent to a covered entity or business associate for treatment, payment, or operations, the applicable redisclosure notice needs to be part of that transaction, whether that is a FHIR-based exchange, an HL7 interface, a billing file, or an API response. This is a workflow and interface design question as much as a legal one: the notice has to be generated consistently, not drafted manually by whoever happens to be sending the record that day.
Audit trails still need to distinguish Part 2 data
Even though segregation is no longer mandatory the way it once effectively was, systems still need to know which records originated from a Part 2 program so they can apply the right consent and redisclosure rules, and so audit logs can show that a disclosure was authorized under a specific consent. The audit logging practices that already apply to HIPAA-covered systems, described in our guide to audit logging in healthcare software, extend naturally to Part 2 data; the difference is what triggers a logged event and what has to be recoverable if a regulator or patient asks for an accounting.
Vendor agreements need updating alongside the software
Because business associates are now treated as Qualified Service Organizations for Part 2 purposes, contracts with cloud hosts, billing vendors, and analytics providers should reflect that. A hosting checklist built around HIPAA alone, such as the considerations in our HIPAA-conscious cloud hosting checklist, is still the right starting point, but Part 2 programs should confirm their QSO agreements explicitly cover the data they are hosting.
Patient-facing access needs the same precision
If patients can view or download Part 2 records through a portal, the same consent and redisclosure logic applies to what the portal displays and to any data the patient chooses to share onward. The authentication, encryption, and access control baseline covered in our piece on patient portal security features applies here too, with Part 2 consent state as an additional access control dimension layered on top.
Common Mistakes When Building for Part 2
- Assuming HIPAA compliance covers Part 2 automatically. They overlap more than before, but Part 2 still has its own consent content requirements and its own definition of what counts as a disclosure.
- Hardcoding a single consent type. Programs may still need multiple consent types for research, legal proceedings, or non-TPO purposes, each with different required elements under 42 CFR 2.31.
- Forgetting the redisclosure statement at integration points. An EHR integration, a FHIR-based exchange described in our FHIR and EHR integration guide, or a simple billing export can all become the place where a missing redisclosure notice turns into a real compliance gap.
- Leaving QSO and business associate paperwork unaligned with the current system design. If the software changed but the contracts did not, the gap usually shows up during an audit, not before.
Frequently Asked Questions
Does 42 CFR Part 2 still require special consent for substance use disorder records?
Yes. The 2024 final rule simplified consent by allowing a single authorization for treatment, payment, and health care operations, but it did not remove the consent requirement itself. Consent still has to meet the specific content requirements in 42 CFR 2.31, including identifying the patient, the information, the purpose, and an expiration date or event.
Is a Part 2 program automatically a HIPAA covered entity?
Not necessarily. Many Part 2 programs are also HIPAA covered entities because they bill electronically, but the two statuses are determined separately. A program can be subject to Part 2 without meeting HIPAA's definition of a covered entity, which is one reason the two frameworks were historically inconsistent.
Do electronic health records need to physically segregate Part 2 data now?
The 2024 rule reduces the practical need for hard segregation by relying on the redisclosure notice instead, but systems still need a reliable way to identify which records are subject to Part 2 so the correct consent and notice logic applies. Many organizations keep some form of tagging or flagging even without full data segregation.
What happens if a Part 2 violation occurs?
The Office for Civil Rights now enforces Part 2 violations using HIPAA's civil and, in applicable cases, criminal penalty framework, which generally replaced Part 2's older and narrower enforcement approach. The specific exposure depends on the nature of the violation and should be assessed with legal counsel.
What should a software vendor ask a behavioral health client before building a Part 2 feature?
Ask whether the organization is a Part 2 program, what consent forms it currently uses, which systems and vendors receive Part 2 data, and whether its business associate and Qualified Service Organization agreements have been updated since the 2024 rule. Those answers determine how much consent logic and redisclosure handling the software actually needs.
Building compliant behavioral health software means getting the consent model, audit trail, and integration points right from the start, not retrofitting them after a vendor review flags a gap. If your team is building or modernizing software that touches substance use disorder records, book a strategy call to talk through the specific workflows involved, or see how Sabyrix approaches healthcare software development more broadly.